ID
45143
Description
Principal Investigator: Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA MeSH: Prostatic Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000330 Seven primary prostate cancers and their paired normal counterparts were DNA-sequenced on a massively parallel sequencing platform. This approach was taken to investigate the genomes for mutations and genomic alterations that would be undetectable by lower-resolution methods. As result, tumors containing chains of balanced rearrangements that occurred within or adjacent to known cancer genes were discovered.
Lien
Mots-clés
Versions (3)
- 08/10/2022 08/10/2022 - Adrian Schulz
- 12/10/2022 12/10/2022 - Adrian Schulz
- 12/10/2022 12/10/2022 - Adrian Schulz
Détendeur de droits
Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA
Téléchargé le
12 octobre 2022
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000330 The Genomic Complexity of Primary Human Prostate Cancer
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject sources, consent form, and affection status of participants affected with prostate cancer.
- Sample ID, subject ID, and sample sources of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor sample characteristics, and demography of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor and normal blood sample characteristics, and subject ID of participants affected with prostate cancer.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject sources, consent form, and affection status of participants affected with prostate cancer.
- Sample ID, subject ID, and sample sources of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor sample characteristics, and demography of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor and normal blood sample characteristics, and subject ID of participants affected with prostate cancer.
C1512693 (UMLS CUI [1,2])